Abstract
In ASCOT, an industry-sponsored randomized trial conducted at 650 general practices across northern Europe, researchers compared the effectiveness of two antihypertensive regimens in 19,257 patients (mean age, 63; 77% men) with hypertension and at least three other cardiovascular risk factors. Baseline hypertension was defined as untreated systolic BP ≥160 mm Hg or diastolic BP ≥100 mm Hg, or treated SBP ≥140 mm Hg or DBP ≥90 mm Hg. One regimen consisted of daily treatment with the calcium-channel blocker amlodipine (5–10 mg), with the ACE inhibitor perindopril …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
